AMDR, Consumer Group Clash Over Reprocessed SUD Risk
This article was originally published in The Gray Sheet
Executive Summary
The Center for Patient Advocacy's recent attempts to focus public attention on the safety risks of reprocessed single-use devices (SUDs) have drawn criticism from the Association of Medical Device Reprocessors